| Literature DB >> 33436830 |
Tomoyuki Makino1, Kouji Izumi2, Kaoru Hiratsuka1, Hiroshi Kano1, Takashi Shimada1, Taito Nakano1, Suguru Kadomoto1, Renato Naito1, Hiroaki Iwamoto1, Hiroshi Yaegashi1, Kazuyoshi Shigehara1, Yoshifumi Kadono1, Hiroki Nakata3, Yohei Saito4, Kyoko Nakagawa-Goto4, Norihiko Sakai5, Yasunori Iwata5, Takashi Wada5, Atsushi Mizokami1.
Abstract
Despite improvements in systemic therapy options for renal cancer, it remains one of the most drug-resistant malignancies. Interestingly, reports have shown that kahweol and cafestol, natural diterpenes extracted from coffee beans, exhibit anti-cancer activity. However, the multiple potential pharmacological actions of both have yet to be fully understood. This study therefore investigated the effects of kahweol acetate and cafestol on human renal cancer ACHN and Caki-1 cells. Accordingly, the combination of kahweol acetate and cafestol administration synergistically inhibited cell proliferation and migration by inducing apoptosis and inhibiting epithelial-mesenchymal transition. Mechanistic dissection revealed that kahweol acetate and cafestol inhibited Akt and ERK phosphorylation. Moreover, kahweol acetate and cafestol downregulated the expression of not only C-C chemokine receptors 2, 5, and 6 but also programmed death-ligand 1, indicating their effects on the tumor microenvironment. Thus, kahweol acetate and cafestol may be novel therapeutic candidates for renal cancer considering that they exert multiple pharmacological effects.Entities:
Year: 2021 PMID: 33436830 PMCID: PMC7804192 DOI: 10.1038/s41598-020-80302-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379